Epidemiology of rosacea in a population-based study of 161,269 German employees
Standard
Epidemiology of rosacea in a population-based study of 161,269 German employees. / Hilbring, Caroline; Augustin, Matthias; Kirsten, Natalia; Mohr, Nicole.
In: INT J DERMATOL, Vol. 61, No. 5, 05.2022, p. 570-576.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Epidemiology of rosacea in a population-based study of 161,269 German employees
AU - Hilbring, Caroline
AU - Augustin, Matthias
AU - Kirsten, Natalia
AU - Mohr, Nicole
N1 - © 2021 The Authors. International Journal of Dermatology published by Wiley Periodicals LLC on behalf of the International Society of Dermatology.
PY - 2022/5
Y1 - 2022/5
N2 - BACKGROUND: Rosacea is a common chronic skin condition, but data on its epidemiology and related comorbidities are scarce.OBJECTIVES: To analyze the prevalence and associated cutaneous comorbidities of rosacea in Germany.METHODS: Voluntary dermatological full-body examinations were conducted between 2001 and 2016 in more than 500 German companies by experienced dermatologists and documented electronically. Point-prevalence rates were calculated, and associations were tested with chi-squared tests and logistic regression analysis.RESULTS: A total of 161,269 participants (mean age was 43.2 ± 10.9 years; 55.5% male) were included; 2.1% had rosacea (men: 2.1%, women 2.1%, mean age 50.7 ± 9.3 years). The prevalence of rosacea increased significantly with age (16-29 years: 0.3%; 30-39 years: 0.9%; 40-49 years: 2.0%; 50-59 years: 3.5%; 60-70 years: 5.7%). Furthermore, there was a significant decreasing prevalence from skin type I toward type IV (skin type I: 3.2%; II: 2.2%; III: 1.5%; IV: 0.4%). The most frequent dermatological comorbidities were: telangiectasia (OR = 2.5), folliculitis (OR = 1.8), seborrheic dermatitis (OR = 1.6), acne (OR = 1.6), tinea pedis (OR = 1.4), psoriasis (OR = 1.4), spider veins (OR = 1.1), and hemangioma (OR = 1.1).CONCLUSIONS: Rosacea is a common skin condition that is most prevalent above the age of 65 years. Rosacea patients have an increased risk for associated comorbidities. Therefore, the diagnostic and therapeutic process for rosacea patients must ensure an integrated, complete dermatological approach in terms of medical care.
AB - BACKGROUND: Rosacea is a common chronic skin condition, but data on its epidemiology and related comorbidities are scarce.OBJECTIVES: To analyze the prevalence and associated cutaneous comorbidities of rosacea in Germany.METHODS: Voluntary dermatological full-body examinations were conducted between 2001 and 2016 in more than 500 German companies by experienced dermatologists and documented electronically. Point-prevalence rates were calculated, and associations were tested with chi-squared tests and logistic regression analysis.RESULTS: A total of 161,269 participants (mean age was 43.2 ± 10.9 years; 55.5% male) were included; 2.1% had rosacea (men: 2.1%, women 2.1%, mean age 50.7 ± 9.3 years). The prevalence of rosacea increased significantly with age (16-29 years: 0.3%; 30-39 years: 0.9%; 40-49 years: 2.0%; 50-59 years: 3.5%; 60-70 years: 5.7%). Furthermore, there was a significant decreasing prevalence from skin type I toward type IV (skin type I: 3.2%; II: 2.2%; III: 1.5%; IV: 0.4%). The most frequent dermatological comorbidities were: telangiectasia (OR = 2.5), folliculitis (OR = 1.8), seborrheic dermatitis (OR = 1.6), acne (OR = 1.6), tinea pedis (OR = 1.4), psoriasis (OR = 1.4), spider veins (OR = 1.1), and hemangioma (OR = 1.1).CONCLUSIONS: Rosacea is a common skin condition that is most prevalent above the age of 65 years. Rosacea patients have an increased risk for associated comorbidities. Therefore, the diagnostic and therapeutic process for rosacea patients must ensure an integrated, complete dermatological approach in terms of medical care.
KW - Acne Vulgaris/epidemiology
KW - Dermatitis, Seborrheic/diagnosis
KW - Female
KW - Humans
KW - Male
KW - Psoriasis/epidemiology
KW - Rosacea/epidemiology
KW - Skin
KW - Telangiectasis/epidemiology
U2 - 10.1111/ijd.15989
DO - 10.1111/ijd.15989
M3 - SCORING: Journal article
C2 - 34897653
VL - 61
SP - 570
EP - 576
JO - INT J DERMATOL
JF - INT J DERMATOL
SN - 0011-9059
IS - 5
ER -